Skip to main navigation
Skip to search
Skip to main content

Oregon Health & Science University Home

Help & FAQ

Home
Profiles
Research units
Core Facilities
Publications

Search by expertise, name or affiliation

Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction

Hagai Tavori, Michelle Melone, Shirya Rashid

Research output: Contribution to journal › Comment/debate › peer-review

Overview
Fingerprint

Fingerprint

Dive into the research topics of 'Correction to: Alirocumab: PCSK9 inhibitor for LDL cholesterol reduction'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Powered by Pure, Scopus & Elsevier Fingerprint Engine™

All content on this site: Copyright © 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply

We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies

About web accessibility

Report vulnerability